TermGallery
English
English
Spanish
Catalan
Portuguese
Russian
EN
English
Español
Català
Português
Русский
1
Subjects were
assessed
at
baseline
and up to 12 months after treatment.
2
All outcomes will be
assessed
at
baseline
,
six months and 12 months.
3
Subjects were
assessed
at
baseline
and again an average of 15months later.
4
Additional psychological attributes were
assessed
at
baseline
and correlated with patient activation.
5
Electromechanical delay and pre-ejection period were
assessed
at
baseline
and maximal HR.
6
Toxicity and drug resistance mutations were
assessed
at
baseline
and follow-up times.
7
Dietary intake was
assessed
at
baseline
and anthropometric measurements were made monthly.
8
Physical fitness, anthropometry and blood markers are
assessed
at
baseline
and post-intervention.
9
Physical activity measurements were also
assessed
at
baseline
and 1 month.
10
Outcome measures were
assessed
at
baseline
and immediately after the intervention.
11
Diet was
assessed
at
baseline
and 5 months later using questionnaires.
12
Screening adherence was
assessed
at
baseline
and at 12 months via self report.
13
Intervention targets were
assessed
at
baseline
,
before each session, and 4-weeks post intervention.
14
Primary and secondary endpoints were
assessed
at
baseline
and Week 48.
15
Cytokines and lymphocyte and monocyte subsets were
assessed
at
baseline
and 12 months.
16
Aspirin use was first
assessed
at
baseline
in 1980 and updated biennially thereafter.